Trulieve Cannabis Analyst Price Targets

PRO

변동 이유?:Trulieve Cannabis shares are trading higher after the company announced it ...

실적: Q3 2026 실적이 목 11월 5th에 개장 전 3일 후 후에 발표됩니다.

컨퍼런스 콜: 3일 후 8:30 오전에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Trulieve Cannabis Analyst Price Targets

Wall Street analyst price targets and consensus rating for Trulieve Cannabis (TRLV).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingOverweight# Analysts1Avg. Consensus PT$15Upside to Avg. PT+34.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 2, 2026	Cantor Fitzgerald	Gabie Ingoglia	Maintained	Overweight	$15
Oct 23, 2026	Cantor Fitzgerald	Gabie Ingoglia	Maintained	Overweight	$15
Aug 7, 2026	Cantor Fitzgerald	Gabie Ingoglia	Maintained	Overweight	$15
Jul 20, 2026	Cantor Fitzgerald	Gabie Ingoglia	Initiate	Overweight	$15

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15

Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.

Benzinga Newsdesk

Trulieve Cannabis Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Trulieve Cannabis Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15

People Also Watch

People Also Watch

Trulieve Cannabis Corp

뉴스

파트너 / 기고자

벤징가 글로벌

Trulieve Cannabis Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PROCantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PROCantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PROCantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15

People Also Watch

People Also Watch

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

PRO
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15